Falls in Parkinson’s disease : Effects on health related quality of life
Objective: Our aim was to assess the effects of falls in PD patients on HrQoL in PD patients. Background: Health related quality of life (HrQoL)…Promoting optimal physiotherapy practice worldwide: Role of the Association of Physiotherapists in Parkinson’s disease Europe (APPDE)
Objective: To illustrate how the APPDE promotes optimal physiotherapy expertise in Europe and the world in the care of people with Parkinson's. Background: The APPDE…Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment
Objective: To trace a clinical and epidemiological profile of patients treated with botulinum toxin, evaluating the impact on quality of life. Background: The Botulinum Toxin…Can body worn cameras help us understand the complex relationship between physical activity and falls in people with Parkinson’s?
Objective: To explore barriers and facilitators to physical activity and examine the relationship with falls for people with Parkinson's (PwP) using body worn cameras. Background:…Clinically ‘slight’ bradykinesia in Parkinson’s disease is accurately detected using evolutionary computation analysis of finger tapping
Objective: To assess whether MDS-UPDRS grade one Parkinson's disease (PD) bradykinesia can be accurately detected by a novel non-invasive device that analyses a standard finger…Evaluation of kinematic parameters of potential clinical use extracted from Microsoft Kinect V2 motor assessments
Objective: To evaluate movement parameters for clinical use extracted from Microsoft Kinect V2 joints. Background: Instrumental motor assessment has been proposed to increase objectivity but…The relevance of movement disorders gene panels in clinical practice: How many patients are we sorting out?
Objective: To investigate the impact of movement disorder gene panels in clinical practice and the proportion of patients receiving a definite genetic diagnosis through Next…The distinguishing clinical features of rapid-onset-parkinson-dystonia (RDP) syndrome due to ATP1A3 mutations
Objective: To determine characteristics that distinguish individuals with presentation suggestive of RDP in ATP1A3 mutation carriers compared with non-carriers. Background: Mutations in the ATP1A3 gene…Alpha-synuclein levels and dimerization in erythrocytes of Parkinson’s disease patients
Objective: To identify possible differences in monomeric/dimeric α-synuclein levels in erythrocytes derived from PD patients from different genetic backgrounds, and check for potential links between…The Faroese Parkinson’s diseases research program-Multifactorial analyses of a complex syndrome
Objective: The program aim is to assess the contribution of genes and environment influencing susceptibility, progression and the relative contribution of risk factors underlying Parkinson's…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 207
- Next Page »